Retinal Ischemia Symptoms Peer-review Journals
Acute retinal arterial ischemia, which incorporates vascular transient sight loss (TMVL or retinal transient ischemic attack), branch retinal arterial occlusion (BRAO), central retinal artery occlusion (CRAO) and arteriaophthalmica occlusion (OAO), may be a classic explanation for acute painless sight loss. Acute retinal arterial
ischemia can be caused by any process that interrupts blood flow through the central retinal artery (CRA). The CRA, which originates from the arteriaophthalmica (the first intracranial branch off the interior carotid artery), mainly supplies blood to the inner retina, including the macula and fovea. TMVL is caused by transient occlusion of the CRA or its branches and causes unilateral vision loss typically lasting several minutes, followed by spontaneous recovery of vision without detectable permanent functional visual deficits. Conversely, BRAO and CRAO are caused by longer-lasting partial or complete occlusion of the CRA or its branches, leading to permanent visual dysfunction [decreased visual acuity and/or visual field deficits. Typically, CRAO produces severe visual dysfunction (very poor acuity and/or severely constricted visual field), while BRAOAcute retinal ischemias are often broadly classified as arteritic, i.e. due to vasculitis, or non-arteritis’, i.e. not due to vasculitis. Except for the paragraph in this section which briefly discusses giant cell arteritis (GCA; temporal arteritis) the terms TMVL, OAO, CRAO, and BRAO will be used to refer to the non-arteritic forms of acute retinal arterial ischemia.
High Impact List of Articles
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
Relevant Topics in Clinical